Zobrazeno 1 - 10
of 29
pro vyhledávání: '"YUCAI CHENG"'
Autor:
ZHIGANG XIA, MENGYAO TIAN, YUCAI CHENG, WENFANG YI, ZEFAN DU1, TIANWEN LI, YUCHEN WEN1, LINDI LI, YONG LIU1, CHUN CHEN
Publikováno v:
Oncology Research; 2024, Vol. 32 Issue 6, p1109-1118, 10p
Autor:
Yixian Li, Yong Liu, Luping Wen, Hui Chen, Wenqing Wang, Mengyao Tian, Yucai Cheng, Hongman Xue, Chun Chen
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
ObjectiveTo summarize the clinical characteristics of children with hematological malignancies co-infected with novel coronavirus and explore the safety and effectiveness of Paxlovid treatment.MethodsFrom December 10, 2022, to January 20, 2023, the c
Externí odkaz:
https://doaj.org/article/8922ba96cb6e4f24865228caeae6ed74
Autor:
Yong Liu, Jing Zhang, Zefan Du, Junbin Huang, Yucai Cheng, Wenfang Yi, Tianwen Li, Jing Yang, Chun Chen
Publikováno v:
Frontiers in Genetics, Vol 13 (2023)
Background: Tyrosyl phosphorylation is carried out by a group of enzymes known as non-receptor protein tyrosine phosphatases (PTPNs). In the current investigation, it is hoped to shed light on the relationships between the expression patterns of PTPN
Externí odkaz:
https://doaj.org/article/1fc1af187c9f4a34b7704e94b68d4862
Autor:
Huabin Wang, Yin Yin, Ru Wang, Junbin Huang, Hongman Xue, Yucai Cheng, Lidan Zhang, Chun Chen
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background A secondary malignancy is the most serious complication in lung cancer (LC) survivors. This study aimed to evaluate the clinicopathological features, predictable risk factors and survival of patients with LC who developed therapy-
Externí odkaz:
https://doaj.org/article/791ad871adc04d43ae7421fef13bb015
Autor:
Lidan Zhang, Yuhui Wu, Huimin Huang, Chunyi Liu, Yucai Cheng, Lingling Xu, Wen Tang, Xuequn Luo
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Objective: The performances of the pediatric risk of mortality score III (PRISM III), pediatric logistic organ dysfunction score-2 (PELOD-2), and pediatric multiple organ dysfunction score (P-MODS) in Chinese patients are unclear. This study aimed to
Externí odkaz:
https://doaj.org/article/4f42653d98ba433094069214da80a459
Autor:
Chao Lin, Guohua Chen, Junbin Huang, Yucai Cheng, Yahong Xu, Airun Zhang, Hongman Xue, Chun Chen
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Vincristine-related secondary hypertension is rare. This study reports two children who were treated with vincristine for acute lymphoblastic leukemia (ALL) and posaconazole for fungal infections who experienced vincristine-related secondary hyperten
Externí odkaz:
https://doaj.org/article/71080ba4f0ba479aa75b43c375d5d745
Autor:
Yong Liu, Jing Zhang, Zefan Du, Junbin Huang, Yucai Cheng, Wenfang Yi, Tianwen Li, Jing Yang, Chun Chen
Spplement material for article "Comprehensive Analysis of PTPN Family Expression and Prognosis in Acute Myeloid Leukemia"
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c97228c6d33c8651d8db20047ef15e62
Autor:
Yong Liu, Jing Zhang, Zefan Du, Junbin Huang, Yucai Cheng, Wenfang Yi, Tianwen Li, Jing Yang, Qiwei Wu, Chun Chen
Spplement material for article "PTPN6: A Novel Diagnostic and Prognostic Target for AMLPTPN6: A Novel Diagnostic and Prognostic Target for AML"
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dfc6713b1d54badb3ccc43485795cf5
Autor:
Yucai Cheng, Xiaoyun Jiang, Su Liu, Shaofen Lin, Junbin Huang, Hongman Xue, Chi Kong Li, Chun Chen, Lifen Huang
Publikováno v:
International Journal of General Medicine
Junbin Huang,1,* Lifen Huang,1,* Su Liu,2 Shaofen Lin,2 Yucai Cheng,1 Xiaoyun Jiang,3 Hongman Xue,1 Chikong Li,4 Chun Chen1 1Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital, Sun Yat-sen University, S
Autor:
Huixia Deng, Beng H. Chong, Mo Yang, Liuming Yang, Qiang Li, Liang Li, Yucai Cheng, Yafang Tan, Jieyu Ye
Publikováno v:
Blood
Background: A previously unknown beta-coronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. The virus was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the international